While many brain-computer interface companies are focused on helping paralyzed people communicate, Motif Neurotech is ...

Akso Health Group (NASDAQ: AHG) ("Akso Health" or the "Company") today announced the commencement of its next-generation, proprietary Brain-Computer Interface (BCI) technology research and development ...

True Corporation Plc's Research and Innovation Centre has partnered with OYMotion, a global leader in neurotechnology, to ...

Motif Neurotech, a brain-computer interface (BCI) company developing technologies for mental health, today announced that the U.S. Food and Drug Administration (FDA) has approved an Investigational ...

Neuvotion, Inc. is an early-stage medical device company developing AI-driven neuromodulation, brain-computer interface (BCI) ...

Motif’s study primarily aims to validate the safety of its XCS system over a 12-month period following implantation.

VisionSys AI Inc. (NASDAQ: VSA) (“VSA” or the “Company”) today announced that it is in advanced discussions with a strategic investor regarding a proposed strategic investment. Based on the terms ...

In the research world, Casey Harrell is known by subject name T-15. He's become a test case, and a point of hope, for people ...

A research team has published details of a brain-computer interface that abandons the conventional approach of ...

Chery officially kicked off its 2026 International Business Summit today, themed 'New Era, New Heights”. Spanning five days, ...

A breakthrough in brain-inspired computing could make today’s energy-hungry AI systems far more efficient. Researchers have engineered a new nanoelectronic device using a modified form of hafnium ...